The activation of RUFY2 is a multifaceted process, influenced by a variety of intracellular signaling molecules and pathways. One such mechanism of activation involves the interplay between RUFY2 and lipid second messengers within the cell membrane. Specific phospholipids, when generated, act as signaling molecules that recruit RUFY2 to membrane sites, enhancing its role in endocytic vesicle formation and trafficking. These lipid molecules interact with RUFY2, modulating its conformation and interaction with other proteins involved in vesicle formation. Similarly, bioactive lipids that engage with G protein-coupled receptors can initiate signaling cascades, ultimately leading to the recruitment and activation of RUFY2, which is pivotal for its function in coordinating cytoskeletal dynamics with membrane trafficking events.
On another front, cyclic nucleotide-mediated pathways provide an avenue for RUFY2 activation through the secondary messenger cAMP and related analogs that elevate its intracellular levels, thereby activating protein kinases that can phosphorylate RUFY2. Such post-translational modifications of RUFY2 are crucial for its function in vesicular trafficking and cargo sorting within the cell. Additionally, the modulation of intracellular calcium through ionophores influences the protein's activity by affecting its interaction with calcium-binding proteins and calcium-dependent kinases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating intracellular cAMP levels, Forskolin indirectly activates PKA, which in turn phosphorylates proteins including RUFY2 to regulate its membrane dynamics and vesicular transport function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
As a bioactive lipid, it binds to its G protein-coupled receptors, initiating signaling cascades that can lead to the activation of RUFY2 by promoting its association with cytoskeletal components. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
A nonhydrolyzable GTP analog that activates GTPases, indirectly influencing RUFY2 by promoting its interaction with GTP-bound Rab proteins, pivotal in vesicle movement and docking. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, subsequently leading to the phosphorylation and activation of RUFY2, which may enhance its function in vesicular trafficking and cargo sorting. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
An activator of PKC which could phosphorylate and thus activate RUFY2, modulating its function in endocytic pathway and membrane dynamics. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that raises intracellular calcium levels, potentially affecting RUFY2 activity by modifying its binding to calcium-dependent adaptor proteins involved in vesicular trafficking. | ||||||
β-Nicotinamide adenine dinucleotide phosphate | 53-59-8 | sc-215560 sc-215560A | 100 mg 250 mg | $182.00 $319.00 | ||
As a cofactor for NADPH oxidase, it generates reactive oxygen species (ROS) which can modulate signaling pathways leading to the activation of RUFY2 in response to oxidative stress. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
A sphingosine analogue that modulates sphingosine phosphate receptors and could thereby affect RUFY2 activity related to membrane trafficking and signaling. | ||||||